Kynam Capital Management, LP
Filing Date
Global Rank
#1,347
/ 8,603
▲ 57
· as of Mar 2026
Top Industry
Biotechnology
95.0%
3Y Alpha vs SPY
+24.0%
Period ended 3 months ago
Filed May 15, 2026 · 55d
18 quarters · since Dec 2021
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+215.6%
SPY
+76.0%
Annualised alpha
+26.0%
Max drawdown
−42.3%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
37 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
11.6%
−2.6 pts
Top 5
51.5%
−4.1 pts
Top 10
71.9%
−2.6 pts
HHI
669
Diversified−88
Portfolio Trend
18 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $1,621,136,956 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
12 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CTMX | CytomX Therapeutics, Inc. | +6,047,016 | 15,013,093 | $70,561,537 | |
| GERN | Geron Corp | +3,380,000 | 6,836,318 | $10,186,113 | |
| TVTX | Travere Therapeutics, Inc. | +1,906,034 | 2,423,918 | $72,014,603 | |
| VRDN | Viridian Therapeutics, Inc.\DE | +871,111 | 2,341,652 | $45,802,713 | |
| PRLD | Prelude Therapeutics Inc | +803,684 | 1,592,551 | $5,446,524 | |
| EVMN | Evommune, Inc. | +440,014 | 625,496 | $14,380,153 | |
| STRO | Sutro Biopharma, Inc. | +392,968 | 872,558 | $21,735,419 | |
| BEAM | Beam Therapeutics Inc. | +304,971 | 3,682,185 | $87,746,468 | |
| BNR | Burning Rock Biotech Ltd | +232,672 | 1,227,555 | $19,800,462 | |
| AMRN | Amarin Corp Plc\Uk | +83,109 | 472,382 | $6,830,643 | |
| IMCR | Immunocore Holdings plc | +28,475 | 884,937 | $26,680,850 | |
| KALV | KalVista Pharmaceuticals, Inc. | +10,000 | 1,820,954 | $36,655,804 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
9 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| BCRX | Biocryst Pharmaceuticals Inc | −3,685,731 | 5,680,795 | $54,081,168 | |
| COGT | Cogent Biosciences, Inc. | −2,127,892 | 4,037,331 | $155,396,870 | |
| WVE | Wave Life Sciences Ltd. | −1,203,912 | 965,193 | $6,997,649 | |
| NRIX | Nurix Therapeutics, Inc. | −775,600 | 1,194,757 | $18,518,733 | |
| ENGN | enGene Therapeutics Inc. | −136,055 | 1,356,843 | $9,240,100 | |
| CLDX | Celldex Therapeutics, Inc. | −102,613 | 5,840,567 | $185,262,785 | |
| APLS | Apellis Pharmaceuticals, Inc. | −83,607 | 825,000 | $33,189,750 | |
| VERA | Vera Therapeutics, Inc. | −34,827 | 3,398,224 | $136,710,551 | |
| CLYM | Climb Bio, Inc. | −25,000 | 1,003,341 | $6,872,885 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
5 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| URGN | UroGen Pharma Ltd. | 2,247,393 | $40,408,126 | |
| LEGN | Legend Biotech Corp | 1,576,295 | $28,515,176 | |
| RVMD | Revolution Medicines, Inc. | 207,500 | $20,179,375 | |
| SLNO | Soleno Therapeutics Inc | 560,000 | $18,748,800 | |
| CADL | Candel Therapeutics, Inc. | 200,000 | $980,000 | |
| No positions match the current search. | ||||
37 positions ·
$1,621,136,956 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Held | 8,050,959 | $188,070,402 | 11.60% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Reduced | 5,840,567 | $185,262,785 | 11.43% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
Held | 2,922,335 | $169,816,886 | 10.48% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Reduced | 4,037,331 | $155,396,870 | 9.59% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Reduced | 3,398,224 | $136,710,551 | 8.43% | |
| BEAM |
Beam Therapeutics Inc.
Healthcare
|
Added | 3,682,185 | $87,746,468 | 5.41% | |
| TVTX |
Travere Therapeutics, Inc.
Healthcare
|
Added | 2,423,918 | $72,014,603 | 4.44% | |
| CTMX |
CytomX Therapeutics, Inc.
Healthcare
|
Added | 15,013,093 | $70,561,537 | 4.35% | |
| BCRX |
Biocryst Pharmaceuticals Inc
Healthcare
|
Reduced | 5,680,795 | $54,081,168 | 3.34% | |
| VRDN |
Viridian Therapeutics, Inc.\DE
Healthcare
|
Added | 2,341,652 | $45,802,713 | 2.83% | |
| CGEM |
Cullinan Therapeutics, Inc.
Healthcare
|
Held | 3,114,132 | $44,251,815 | 2.73% | |
| URGN |
UroGen Pharma Ltd.
Healthcare
|
NEW | 2,247,393 | $40,408,126 | 2.49% | |
| KALV |
KalVista Pharmaceuticals, Inc.
Healthcare
|
Added | 1,820,954 | $36,655,804 | 2.26% | |
| APLS |
Apellis Pharmaceuticals, Inc.
Healthcare
|
Reduced | 825,000 | $33,189,750 | 2.05% | |
| LEGN |
Legend Biotech Corp
Healthcare
|
NEW | 1,576,295 | $28,515,176 | 1.76% | |
| MBX |
MBX Biosciences, Inc.
Healthcare
|
Held | 934,799 | $27,903,750 | 1.72% | |
| IMCR |
Immunocore Holdings plc
Healthcare
|
Added | 884,937 | $26,680,850 | 1.65% | |
| STRO |
Sutro Biopharma, Inc.
Healthcare
|
Added | 872,558 | $21,735,419 | 1.34% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
NEW | 207,500 | $20,179,375 | 1.24% | |
| BNR |
Burning Rock Biotech Ltd
Healthcare
|
Added | 1,227,555 | $19,800,462 | 1.22% | |
| SLNO |
Soleno Therapeutics Inc
Healthcare
|
NEW | 560,000 | $18,748,800 | 1.16% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
Reduced | 1,194,757 | $18,518,733 | 1.14% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
Held | 640,395 | $18,091,158 | 1.12% | |
| EVMN |
Evommune, Inc.
Healthcare
|
Added | 625,496 | $14,380,153 | 0.89% | |
| RLAY |
Relay Therapeutics, Inc.
Healthcare
|
Held | 1,424,259 | $14,171,377 | 0.87% | |
| GERN |
Geron Corp
Healthcare
|
Added | 6,836,318 | $10,186,113 | 0.63% | |
| ENGN |
enGene Therapeutics Inc.
Healthcare
|
Reduced | 1,356,843 | $9,240,100 | 0.57% | |
| DSGN |
Design Therapeutics, Inc.
Healthcare
|
Held | 784,606 | $8,348,207 | 0.51% | |
| WVE |
Wave Life Sciences Ltd.
Healthcare
|
Reduced | 965,193 | $6,997,649 | 0.43% | |
| CLYM |
Climb Bio, Inc.
Healthcare
|
Reduced | 1,003,341 | $6,872,885 | 0.42% | |
| AMRN |
Amarin Corp Plc\Uk
Healthcare
|
Added | 472,382 | $6,830,643 | 0.42% | |
| BHVN |
Biohaven Ltd.
Healthcare
|
Held | 702,884 | $5,946,398 | 0.37% | |
| PRLD |
Prelude Therapeutics Inc
Healthcare
|
Added | 1,592,551 | $5,446,524 | 0.34% | |
| CRBU |
Caribou Biosciences, Inc.
Healthcare
|
Held | 2,503,302 | $4,756,273 | 0.29% | |
| ALEC |
Alector, Inc.
Healthcare
|
Held | 2,000,000 | $4,300,000 | 0.27% | |
| PRQR |
ProQR Therapeutics N.V.
Healthcare
|
Held | 1,566,317 | $2,537,433 | 0.16% | |
| CADL |
Candel Therapeutics, Inc.
Healthcare
|
NEW | 200,000 | $980,000 | 0.06% |